Desvenlafaxine Succinate

Product NDC: 59762-1222
11-digit product format: 597621222
Labeler code: 59762
Product ID: 59762-1222_8b591edd-a797-4d94-9b0f-74e046df7e67
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: desvenlafaxine succinate
Dosage form: TABLET, EXTENDED RELEASE
Route: ORAL
Labeler: Greenstone LLC
Application: NDA021992
Marketing category: NDA AUTHORIZED GENERIC
Marketing start: 2017-03-01
Marketing end: 0000-00-00
Substance: DESVENLAFAXINE SUCCINATE
Active strength: 100 mg/1
Pharmacologic classes: Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
59762-1222-3	2024-01-30	C162847	48780-1	1030e365-48e1-111a-e063-dadaa90a10e2	7195b977-6c91-4fed-837d-9b146f051ce8

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
59762-1222-3	EA - Each	59762-1222	92069df7-3ec1-4e43-b1ca-3b825c80d443	1	2017-04-05

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
ZB22ENF0XR	DESVENLAFAXINE SUCCINATE	386750-22-7	DESVENLAFAXINE SUCCINATE

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
59762-1222-3	59762122203	30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (59762-1222-3)	2017-03-01	0000-00-00	No	No	Current